Find clinical trials for Diabetes in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near New York, NY, USA:
enhanced with continuous glucose monitor (CGM) review to target diabetes distress in adults with type 1 diabetes. The efficacy of C...
New York, New York, United States and 2 other locations
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
New Brunswick, New Jersey, United States and 44 other locations
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
The Bronx, New York, United States and 18 other locations
Pregnant women aged 18-40 with gestational diabetes (GDM) will take part in this study. We want to see how two different insulin treatments ...
Phase 2, Phase 3
New York City, New York, United States and 4 other locations
evaluate the effect of a behavioral intervention on the number of preventive and treatment dental claims in a population of people with Type 2 Diabetes...
Phase 4
Long Island City, New York, United States
) found that consumption of 1 serving (cup) of milk/day was associated with \~30% lower risk of type 2 diabetes among LNP individuals, but n...
The Bronx, New York, United States
of the fully closed loop Omnipod M System in adults with type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy, wi...
New York, New York, United States and 18 other locations
The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...
Phase 3
Laurelton, New York, United States and 57 other locations
enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes...
The Bronx, New York, United States and 2 other locations
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
New York, New York, United States and 96 other locations
Clinical trials
Research sites
Resources
Legal